Post a Comment Print Share on Facebook

Coronavirus, the risk of shortages of medicines in Europe

The closure extended to companies in China, two months after the discovery of the coronavirus, seriously jeopardises the supply of raw materials necessary to pr

- 113 reads.

Coronavirus, the risk of shortages of medicines in Europe
The closure extended to companies in China, two months after the discovery of the coronavirus, seriously jeopardises the supply of raw materials necessary to produce drugs and threatens to cause a shortage of medicines in Europe. The warning comes from France, through the Academie nationale de Pharmacie, which the press release claims that "the epidemic of Covid-19 in China could pose a serious threat on public health in France and in Europe, since 80% of the active pharmaceutical ingredients used in the Old Continent, there are products outside the european economic area, the most in Asia".

The Academy stresses the fact that "because of the many links in the chain of production, just a natural disaster or health event, a geopolitical, an industrial accident, to lead to the interruption of the supply of drugs that could become scarce for the same patients in care."
Avatar
Your Name
Post a Comment
Characters Left:
Your comment has been forwarded to the administrator for approval.×
Warning! Will constitute a criminal offense, illegal, threatening, offensive, insulting and swearing, derogatory, defamatory, vulgar, pornographic, indecent, personality rights, damaging or similar nature in the nature of all kinds of financial content, legal, criminal and administrative responsibility for the content of the sender member / members are belong.